Silmo Paris once again proved to be the global stage for the optical industry’s future. From September 26 to 29, 2025, the event brought together 33,358 professionals — with 52% international visitors — marking a 6.5% increase in attendance.
Zeiss Vision Care announced the acquisition of a 10% stake in Ocumeda AG (“Ocumeda”) from the Fielmann Group for €10 million.
The Rodenstock Group, a global leader in eye health innovation and manufacturer of biometric lenses, will complete its Executive Management Team with the appointment of Dr Martina Bentele as CFO, effective February 1st, 2026.
EssilorLuxottica announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway.
This last summer the traditional yearly Lensware convention took place at the headquarters in Langen, Germany, welcoming all its consultants, arriving from all continents.
IXI, one pioneer behind innovative autofocus glasses, announced at Silmo two strategic moves to further its mission of building the future of eyewear by strengthening its production pipeline in Europe.
After several years of joint development, Optotech and Zeiss Vision Care are introducing an innovation in ophthalmic lens production: an eco-friendly manufacturing technology that replaces the conventional blocking process based on alloy or plastic adhesive.
EssilorLuxottica and Meta Platforms showcased the evolution of their celebrated partnership at Meta Connect, where they unveiled the next generation of AI glasses.
The Swiss lens manufacturer Optiswiss and the UK-based lens company Deepcove Optical announced the signing of a long-term exclusive distribution agreement for the UK market, further strengthening their decade-long collaboration.
The Vision Council released a new two-part research report, Focused inSights 2025: Myopia Management, combining a global analysis of pediatric myopia treatment strategies with a survey of U.S. eyecare providers.
